For the year ended 31 May 2019
| Download (EXCEL) |
| Notes | 2019 R'000 |
2018 R'000 |
||||
| Cash flows from operating activities | ||||||
| Cash received from customers | 25 995 287 | 23 588 810 | ||||
| Cash paid to suppliers, financiers and employees | (25 564 000) | (20 000 031) | ||||
| Cash generated by operations | 1.6 | 431 287 | 3 588 779 | |||
| Interest received | 88 416 | 154 952 | ||||
| Interest paid | (231 131) | (187 489) | ||||
| Taxation paid | (369 086) | (368 099) | ||||
| Net cash (utilised in)/generated from operating activities | (80 514) | 3 188 143 | ||||
| Cash flows from investing activities | ||||||
| Acquisition of intangible assets | 4.2 | (75 931) | (31 183) | |||
| Proceeds on disposal of intangible assets | 51 | — | ||||
| Proceeds on disposal of property, plant and equipment | 5 230 | 6 486 | ||||
| Acquisition of property, plant and equipment | 4.3 | (134 028) | (71 640) | |||
| Acquisition of subsidiary net of cash acquired | 2.4 | (7 162) | (291 240) | |||
| Acquisition of associate | — | (6 124 127) | ||||
| Transaction costs on associates | — | (55 131) | ||||
| Capital contribution to Oxigen Services India | — | (25 076) | ||||
| Purchase of bond notes | 3.7 | — | (117 037) | |||
| Liquidity support granted | 3.7 | (326 388) | — | |||
| Loan repaid by Cell C | 1 135 759 | — | ||||
| Loan granted to Cell C | (106 132) | (1 017 522) | ||||
| Loans advanced to associates and joint ventures | (13 284) | (31 641) | ||||
| Loans repaid by associates and joint ventures | 1 690 | — | ||||
| Dividend received from associate and joint venture | 17 992 | 4 251 | ||||
| Loans granted | (29 916) | (54 981) | ||||
| Loans receivable repaid | 96 007 | 78 329 | ||||
| Settlement of contingent consideration | (2 614) | (27 867) | ||||
| Net cash generated by/(utilised in) investing activities | 561 274 | (7 758 379) | ||||
| Cash flows from financing activities | ||||||
| Interest-bearing borrowings raised | 3.6.2 | 993 439 | 935 442 | |||
| Interest-bearing borrowings repaid | 3.6.2 | (769 652) | — | |||
| Non-interest-bearing borrowings raised | 3.6.2 | 35 876 | — | |||
| Non-interest-bearing borrowings repaid | 3.6.2 | (170) | (58) | |||
| Proceeds from shares issued | 6.1 | — | 3 650 000 | |||
| Transaction costs on share issue | — | (12 424) | ||||
| Share buy-back | (224 006) | — | ||||
| Acquisition of treasury shares | 6.1 | (42 378) | (28 846) | |||
| Dividends paid to non-controlling interest | (35 550) | (27 750) | ||||
| Dividends paid to equity holders of the parent | — | (349 804) | ||||
| Net cash (utilised in)/generated by financing activities | (42 441) | 4 166 560 | ||||
| Net increase/(decrease) in cash and cash equivalents | 438 319 | (403 676) | ||||
| Cash and cash equivalents at the beginning of the year | 947 888 | 1 350 666 | ||||
| Exchange gains on cash and cash equivalents | (8 454) | 898 | ||||
| Cash and cash equivalents at the end of the year | 3.5.4 | 1 377 753 | 947 888 |